Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis

Clinical trial NCT00216372 · COMPLETED

Trial details

NCT number: NCT00216372
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Intestinal Obstruction Carcinoma Peritoneal Neoplasms

Start date: 2003-09-01
Primary completion: 2008-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.